The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
False‐Positive Galactomannan Platelia Aspergillus Test Results for Patients Receiving Piperacillin‐Tazobactam
Open accessAbstract
At the bone marrow transplantation center of the San Martino Hospital (Genoa), we observed an increase in the rate of patients with positive Platelia Aspergillus (PA; Bio-Rad) test results, from 10% (38 of 386 patients) in the period from January 1999 through January 2003 to 36% (21 of 59 patients) in the period from February 2003 through May 2003. Positivity was significantly (P<.001) associated with the administration of piperacillin-tazobactam (PT) (17 [74%] of 23 patients who received PT had positive results vs. 4 [11%] of 36 who did not receive PT). Multivariate analysis found administration of PT ( chi 2=34.7; P<.001) and underlying disease ( chi 2=21.14; P<.001) to be associated with PA positivity. Of 15 PT batches tested, 12 had positive PA test results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Rat monoclonal antibodies against Aspergillus galactomannan
Stynen, D., Sarfati, J., Goris, A., Prévost, M. C., Lesourd, M., Kamphuis, H., Darras, V, & Latgé, J. P. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2237-2245.1992 · Cited by 267
Cited by
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Du Rand, I. A., Blaikley, J., Booton, R., Chaudhuri, N., Gupta, V, Khalid, S., Mandal, S., Martin, J., Mills, J., Navani, N., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203618 · Cited by 920
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J.-W., Stark, P., Durand, C., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 594
Aspergillus Infections in Transplant Recipients
Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Bulpa, P., Dive, A., & Sibille, Y. (2007) · European Respiratory Journal · doi:10.1183/09031936.00062206 · Cited by 466
Evaluation of a (1→3)-β- d -Glucan Assay for Diagnosis of Invasive Fungal Infections
Pickering, J. W., Sant, H. W., Bowles, C. A. P., Roberts, W. L., & Woods, G. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5957-5962.2005 · Cited by 379
Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients
Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Leeflang, M. M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., & Vandenbroucke-Grauls, C. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394 · Cited by 362
Thornton, C. R. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00068-08 · Cited by 226
“Contamination of -lactam antibiotics with Penicillium GM may account for the serum reactivity of patients receiving piperacillin-tazobactam or amoxicillin-clavulanic acid (2, 20, 39, 40), although these reports have been disputed (46).”
Herbrecht, R., Maertens, J., Baila, L., Aoun, M., Heinz, W., Martino, R., Schwartz, S., Ullmann, A. J., Meert, L., Paesmans, M., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.334 · Cited by 149
Self-citationContemporary tools for the diagnosis and management of invasive mycoses
Alexander, B. D., & Pfaller, M. A. (2006) · Clinical Infectious Diseases · doi:10.1086/504491 · Cited by 147
Heng, S. C., Morrissey, O., Chen, S. C.-A., Thursky, K., Manser, R. L., Nation, R. L., Kong, D. C.-M., & Slavin, M. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.804033 · Cited by 133
Diagnosis of invasive aspergillosis: recent developments and ongoing challenges
Arvanitis, M., & Mylonakis, E. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12448 · Cited by 56
Zhang, L., Guo, Z., Xie, S., Zhou, J., Chen, G., Feng, J., & Huang, Y. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.08.005 · Cited by 36
Diagnostic Approaches for Invasive Aspergillosis—Specific Considerations in the Pediatric Population
Lehrnbecher, T., Hassler, A., Groll, A. H., & Bochennek, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00518 · Cited by 29
“, Histoplasma capsulatum,Cryptococcus neoformans) (Viscoli et al., 2004).”
BackgroundDiagnostics and Susceptibility Testing in Aspergillus
Bernal-Martínez, L., Alastruey-Izquierdo, A., & Cuenca-Estrella, M. (2016) · Future Microbiology · doi:10.2217/fmb.15.140 · Cited by 25
Metadata
- Authors
- Viscoli, C., Machetti, M., Cappellano, P., Bucci, B., Bruzzi, P., Lint, M. T. V., & Bacigalupo, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-15
- Volume
- 38
- Issue
- 6
- Pages
- 913-916
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108781643
- Cited by
- 244
- References
- 2
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.